Physician profile
Mark Philip Smith
NPI 1306465901
$3,241.92
in general payments reported to CMS, 2019-2025
10 companies · $2,952 in 2025
The $2,952 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $290 · 2025: $2,952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,651 · Travel and Lodging: $1,091 · Education: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,651.04 |
| Travel and Lodging | $1,090.88 |
| Education | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,048.25 | 2024-2025 | Aequalis Perform Reversed, T2 Alpha, Bio4 |
| Axogen | $1,001.21 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Medartis INC. | $602.16 | 2025 | Aptus |
| Ebi, LLC | $145.53 | 2025 | Biomet Ebi Bone Healing System |
| Highridge Medical LLC | $145.53 | 2025 | Biomet Ebi Bone Healing System |
| Anika Therapeutics, INC. | $129.30 | 2024 | Integrity |
| Depuy Synthes Sales INC. | $69.31 | 2025 | Na |
| Bone Support INC. | $64.73 | 2024 | Ceramentbone Void Filler, Cerament G |
| Mf Med | $20.12 | 2025 | |
| Endo USA, INC. | $15.78 | 2025 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.